Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 25 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-25-2021-2

Cadila Healthcare Limited has informed the Exchange regarding a press release dated March 25, 2021, titled "Zydus Cadila receives tentative approval from the USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases